Page 90 - Developing News Today

LONDON, June 06, 2023 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, has posted notice of its Annual General... | June 6, 2023

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, June 6, 2023 /PRNewswire/ - ESSA Pharma Inc. , a clinical-stage pharmaceutical company focused on developing novel therapies for the... | June 6, 2023

MyJournals.org - Science - Remote Sensing, Vol. 15, Pages 2948: Developing Spatial and Temporal Continuous Fractional Vegetation Cover Based on Landsat and Sentinel-2 Data with a Deep Learning Approach (Remote Sensing)

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Announces successful dosing of first test subjects in a randomised,... | June 6, 2023

Minister of International Development and Minister responsible for the Pacific Economic Development Agency, Harjit S. Sajjan, announced on World Environment Day, which was celebrated on June 5, that Canada will host the Seventh Assembly of the Global Environment Facility (GEF) in Vancouver, British Columbia, from August 22 to 26.Afte

Premier African Minerals Ltd - Africa-focused company developing a portfolio of metals and minerals projects - Updates on the offtake and prepayment agreement between itself and Canmax Technologies... | June 6, 2023

Edgewise Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle... | June 6, 2023

NAARDEN, the Netherlands and MIAMI, June 06, 2023 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of... | June 6, 2023

SYDNEY, June 6 (Xinhua) -- A new study led by the University of Sydney has revealed that undertaking regular physical activity could lower the risk of type 2 di

Reata Pharmaceuticals, Inc. , a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced that management will... | June 6, 2023